Global Flow Cytometry in Oncology Market Size, Status and Forecast 2023-2027

Report ID: 933492 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Flow Cytometry in Oncology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Assays and Kits
        1.2.3 Instruments
        1.2.4 Reagents and Consumables
        1.2.5 Software
    1.3 Market by Application
        1.3.1 Global Flow Cytometry in Oncology Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Diagnostic Laboratories
        1.3.3 Hospitals and Healthcare Centers
        1.3.4 Academic and Research Institutions
        1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
    2.1 Global Flow Cytometry in Oncology Market Perspective (2016-2027)
    2.2 Flow Cytometry in Oncology Growth Trends by Regions
        2.2.1 Flow Cytometry in Oncology Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Flow Cytometry in Oncology Historic Market Share by Regions (2016-2021)
        2.2.3 Flow Cytometry in Oncology Forecasted Market Size by Regions (2022-2027)
    2.3 Flow Cytometry in Oncology Industry Dynamic
        2.3.1 Flow Cytometry in Oncology Market Trends
        2.3.2 Flow Cytometry in Oncology Market Drivers
        2.3.3 Flow Cytometry in Oncology Market Challenges
        2.3.4 Flow Cytometry in Oncology Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Flow Cytometry in Oncology Players by Revenue
        3.1.1 Global Top Flow Cytometry in Oncology Players by Revenue (2016-2021)
        3.1.2 Global Flow Cytometry in Oncology Revenue Market Share by Players (2016-2021)
    3.2 Global Flow Cytometry in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Flow Cytometry in Oncology Revenue
    3.4 Global Flow Cytometry in Oncology Market Concentration Ratio
        3.4.1 Global Flow Cytometry in Oncology Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Flow Cytometry in Oncology Revenue in 2020
    3.5 Flow Cytometry in Oncology Key Players Head office and Area Served
    3.6 Key Players Flow Cytometry in Oncology Product Solution and Service
    3.7 Date of Enter into Flow Cytometry in Oncology Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Flow Cytometry in Oncology Breakdown Data by Type
    4.1 Global Flow Cytometry in Oncology Historic Market Size by Type (2016-2021)
    4.2 Global Flow Cytometry in Oncology Forecasted Market Size by Type (2022-2027)

5 Flow Cytometry in Oncology Breakdown Data by Application
    5.1 Global Flow Cytometry in Oncology Historic Market Size by Application (2016-2021)
    5.2 Global Flow Cytometry in Oncology Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Flow Cytometry in Oncology Market Size (2016-2027)
    6.2 North America Flow Cytometry in Oncology Market Size by Type
        6.2.1 North America Flow Cytometry in Oncology Market Size by Type (2016-2021)
        6.2.2 North America Flow Cytometry in Oncology Market Size by Type (2022-2027)
        6.2.3 North America Flow Cytometry in Oncology Market Size by Type (2016-2027)
    6.3 North America Flow Cytometry in Oncology Market Size by Application
        6.3.1 North America Flow Cytometry in Oncology Market Size by Application (2016-2021)
        6.3.2 North America Flow Cytometry in Oncology Market Size by Application (2022-2027)
        6.3.3 North America Flow Cytometry in Oncology Market Size by Application (2016-2027)
    6.4 North America Flow Cytometry in Oncology Market Size by Country
        6.4.1 North America Flow Cytometry in Oncology Market Size by Country (2016-2021)
        6.4.2 North America Flow Cytometry in Oncology Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Flow Cytometry in Oncology Market Size (2016-2027)
    7.2 Europe Flow Cytometry in Oncology Market Size by Type
        7.2.1 Europe Flow Cytometry in Oncology Market Size by Type (2016-2021)
        7.2.2 Europe Flow Cytometry in Oncology Market Size by Type (2022-2027)
        7.2.3 Europe Flow Cytometry in Oncology Market Size by Type (2016-2027)
    7.3 Europe Flow Cytometry in Oncology Market Size by Application
        7.3.1 Europe Flow Cytometry in Oncology Market Size by Application (2016-2021)
        7.3.2 Europe Flow Cytometry in Oncology Market Size by Application (2022-2027)
        7.3.3 Europe Flow Cytometry in Oncology Market Size by Application (2016-2027)
    7.4 Europe Flow Cytometry in Oncology Market Size by Country
        7.4.1 Europe Flow Cytometry in Oncology Market Size by Country (2016-2021)
        7.4.2 Europe Flow Cytometry in Oncology Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Flow Cytometry in Oncology Market Size (2016-2027)
    8.2 Asia-Pacific Flow Cytometry in Oncology Market Size by Type
        8.2.1 Asia-Pacific Flow Cytometry in Oncology Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Flow Cytometry in Oncology Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Flow Cytometry in Oncology Market Size by Type (2016-2027)
    8.3 Asia-Pacific Flow Cytometry in Oncology Market Size by Application
        8.3.1 Asia-Pacific Flow Cytometry in Oncology Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Flow Cytometry in Oncology Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Flow Cytometry in Oncology Market Size by Application (2016-2027)
    8.4 Asia-Pacific Flow Cytometry in Oncology Market Size by Region
        8.4.1 Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Flow Cytometry in Oncology Market Size (2016-2027)
    9.2 Latin America Flow Cytometry in Oncology Market Size by Type
        9.2.1 Latin America Flow Cytometry in Oncology Market Size by Type (2016-2021)
        9.2.2 Latin America Flow Cytometry in Oncology Market Size by Type (2022-2027)
        9.2.3 Latin America Flow Cytometry in Oncology Market Size by Type (2016-2027)
    9.3 Latin America Flow Cytometry in Oncology Market Size by Application
        9.3.1 Latin America Flow Cytometry in Oncology Market Size by Application (2016-2021)
        9.3.2 Latin America Flow Cytometry in Oncology Market Size by Application (2022-2027)
        9.3.3 Latin America Flow Cytometry in Oncology Market Size by Application (2016-2027)
    9.4 Latin America Flow Cytometry in Oncology Market Size by Country
        9.4.1 Latin America Flow Cytometry in Oncology Market Size by Country (2016-2021)
        9.4.2 Latin America Flow Cytometry in Oncology Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Flow Cytometry in Oncology Market Size (2016-2027)
    10.2 Middle East & Africa Flow Cytometry in Oncology Market Size by Type
        10.2.1 Middle East & Africa Flow Cytometry in Oncology Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Flow Cytometry in Oncology Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Flow Cytometry in Oncology Market Size by Type (2016-2027)
    10.3 Middle East & Africa Flow Cytometry in Oncology Market Size by Application
        10.3.1 Middle East & Africa Flow Cytometry in Oncology Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Flow Cytometry in Oncology Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Flow Cytometry in Oncology Market Size by Application (2016-2027)
    10.4 Middle East & Africa Flow Cytometry in Oncology Market Size by Country
        10.4.1 Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Agilent Technologies, Inc.
        11.1.1 Agilent Technologies, Inc. Company Details
        11.1.2 Agilent Technologies, Inc. Business Overview
        11.1.3 Agilent Technologies, Inc. Flow Cytometry in Oncology Introduction
        11.1.4 Agilent Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.1.5 Agilent Technologies, Inc. Recent Development
    11.2 Apogee Flow Systems Ltd.
        11.2.1 Apogee Flow Systems Ltd. Company Details
        11.2.2 Apogee Flow Systems Ltd. Business Overview
        11.2.3 Apogee Flow Systems Ltd. Flow Cytometry in Oncology Introduction
        11.2.4 Apogee Flow Systems Ltd. Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.2.5 Apogee Flow Systems Ltd. Recent Development
    11.3 Becton, Dickinson and Company
        11.3.1 Becton, Dickinson and Company Company Details
        11.3.2 Becton, Dickinson and Company Business Overview
        11.3.3 Becton, Dickinson and Company Flow Cytometry in Oncology Introduction
        11.3.4 Becton, Dickinson and Company Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.3.5 Becton, Dickinson and Company Recent Development
    11.4 bioAffinity Technologies, Inc.
        11.4.1 bioAffinity Technologies, Inc. Company Details
        11.4.2 bioAffinity Technologies, Inc. Business Overview
        11.4.3 bioAffinity Technologies, Inc. Flow Cytometry in Oncology Introduction
        11.4.4 bioAffinity Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.4.5 bioAffinity Technologies, Inc. Recent Development
    11.5 Bio-Rad Laboratories, Inc.
        11.5.1 Bio-Rad Laboratories, Inc. Company Details
        11.5.2 Bio-Rad Laboratories, Inc. Business Overview
        11.5.3 Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Introduction
        11.5.4 Bio-Rad Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.5.5 Bio-Rad Laboratories, Inc. Recent Development
    11.6 Bio-Techne Corporation Cytek Biosciences
        11.6.1 Bio-Techne Corporation Cytek Biosciences Company Details
        11.6.2 Bio-Techne Corporation Cytek Biosciences Business Overview
        11.6.3 Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Introduction
        11.6.4 Bio-Techne Corporation Cytek Biosciences Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.6.5 Bio-Techne Corporation Cytek Biosciences Recent Development
    11.7 Cytognos, S.L.
        11.7.1 Cytognos, S.L. Company Details
        11.7.2 Cytognos, S.L. Business Overview
        11.7.3 Cytognos, S.L. Flow Cytometry in Oncology Introduction
        11.7.4 Cytognos, S.L. Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.7.5 Cytognos, S.L. Recent Development
    11.8 Danaher Corporation
        11.8.1 Danaher Corporation Company Details
        11.8.2 Danaher Corporation Business Overview
        11.8.3 Danaher Corporation Flow Cytometry in Oncology Introduction
        11.8.4 Danaher Corporation Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.8.5 Danaher Corporation Recent Development
    11.9 Miltenyi Biotec B.V. and Co. KG
        11.9.1 Miltenyi Biotec B.V. and Co. KG Company Details
        11.9.2 Miltenyi Biotec B.V. and Co. KG Business Overview
        11.9.3 Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Introduction
        11.9.4 Miltenyi Biotec B.V. and Co. KG Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.9.5 Miltenyi Biotec B.V. and Co. KG Recent Development
    11.10 Laboratory Corporation of America Holdings
        11.10.1 Laboratory Corporation of America Holdings Company Details
        11.10.2 Laboratory Corporation of America Holdings Business Overview
        11.10.3 Laboratory Corporation of America Holdings Flow Cytometry in Oncology Introduction
        11.10.4 Laboratory Corporation of America Holdings Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.10.5 Laboratory Corporation of America Holdings Recent Development
    11.11 Luminex Corporation
        11.11.1 Luminex Corporation Company Details
        11.11.2 Luminex Corporation Business Overview
        11.11.3 Luminex Corporation Flow Cytometry in Oncology Introduction
        11.11.4 Luminex Corporation Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.11.5 Luminex Corporation Recent Development
    11.12 NeoGenomics Laboratories, Inc.
        11.12.1 NeoGenomics Laboratories, Inc. Company Details
        11.12.2 NeoGenomics Laboratories, Inc. Business Overview
        11.12.3 NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Introduction
        11.12.4 NeoGenomics Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.12.5 NeoGenomics Laboratories, Inc. Recent Development
    11.13 Sony Corporation
        11.13.1 Sony Corporation Company Details
        11.13.2 Sony Corporation Business Overview
        11.13.3 Sony Corporation Flow Cytometry in Oncology Introduction
        11.13.4 Sony Corporation Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.13.5 Sony Corporation Recent Development
    11.14 Thermo Fisher Scientific Inc
        11.14.1 Thermo Fisher Scientific Inc Company Details
        11.14.2 Thermo Fisher Scientific Inc Business Overview
        11.14.3 Thermo Fisher Scientific Inc Flow Cytometry in Oncology Introduction
        11.14.4 Thermo Fisher Scientific Inc Revenue in Flow Cytometry in Oncology Business (2016-2021)
        11.14.5 Thermo Fisher Scientific Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Flow Cytometry in Oncology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Assays and Kits
    Table 3. Key Players of Instruments
    Table 4. Key Players of Reagents and Consumables
    Table 5. Key Players of Software
    Table 6. Global Flow Cytometry in Oncology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Flow Cytometry in Oncology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Flow Cytometry in Oncology Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Flow Cytometry in Oncology Market Share by Regions (2016-2021)
    Table 10. Global Flow Cytometry in Oncology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Flow Cytometry in Oncology Market Share by Regions (2022-2027)
    Table 12. Flow Cytometry in Oncology Market Trends
    Table 13. Flow Cytometry in Oncology Market Drivers
    Table 14. Flow Cytometry in Oncology Market Challenges
    Table 15. Flow Cytometry in Oncology Market Restraints
    Table 16. Global Flow Cytometry in Oncology Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Flow Cytometry in Oncology Market Share by Players (2016-2021)
    Table 18. Global Top Flow Cytometry in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flow Cytometry in Oncology as of 2020)
    Table 19. Ranking of Global Top Flow Cytometry in Oncology Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Flow Cytometry in Oncology Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Flow Cytometry in Oncology Product Solution and Service
    Table 23. Date of Enter into Flow Cytometry in Oncology Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Flow Cytometry in Oncology Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Flow Cytometry in Oncology Revenue Market Share by Type (2016-2021)
    Table 27. Global Flow Cytometry in Oncology Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Flow Cytometry in Oncology Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Flow Cytometry in Oncology Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Flow Cytometry in Oncology Revenue Market Share by Application (2016-2021)
    Table 31. Global Flow Cytometry in Oncology Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Flow Cytometry in Oncology Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Flow Cytometry in Oncology Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Flow Cytometry in Oncology Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Flow Cytometry in Oncology Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Flow Cytometry in Oncology Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Flow Cytometry in Oncology Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Flow Cytometry in Oncology Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Flow Cytometry in Oncology Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Flow Cytometry in Oncology Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Flow Cytometry in Oncology Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Flow Cytometry in Oncology Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Flow Cytometry in Oncology Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Flow Cytometry in Oncology Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Flow Cytometry in Oncology Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Flow Cytometry in Oncology Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Flow Cytometry in Oncology Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Flow Cytometry in Oncology Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Flow Cytometry in Oncology Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Flow Cytometry in Oncology Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Flow Cytometry in Oncology Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Flow Cytometry in Oncology Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Flow Cytometry in Oncology Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Flow Cytometry in Oncology Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Flow Cytometry in Oncology Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Flow Cytometry in Oncology Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Flow Cytometry in Oncology Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Flow Cytometry in Oncology Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Agilent Technologies, Inc. Company Details
    Table 64. Agilent Technologies, Inc. Business Overview
    Table 65. Agilent Technologies, Inc. Flow Cytometry in Oncology Product
    Table 66. Agilent Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 67. Agilent Technologies, Inc. Recent Development
    Table 68. Apogee Flow Systems Ltd. Company Details
    Table 69. Apogee Flow Systems Ltd. Business Overview
    Table 70. Apogee Flow Systems Ltd. Flow Cytometry in Oncology Product
    Table 71. Apogee Flow Systems Ltd. Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 72. Apogee Flow Systems Ltd. Recent Development
    Table 73. Becton, Dickinson and Company Company Details
    Table 74. Becton, Dickinson and Company Business Overview
    Table 75. Becton, Dickinson and Company Flow Cytometry in Oncology Product
    Table 76. Becton, Dickinson and Company Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 77. Becton, Dickinson and Company Recent Development
    Table 78. bioAffinity Technologies, Inc. Company Details
    Table 79. bioAffinity Technologies, Inc. Business Overview
    Table 80. bioAffinity Technologies, Inc. Flow Cytometry in Oncology Product
    Table 81. bioAffinity Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 82. bioAffinity Technologies, Inc. Recent Development
    Table 83. Bio-Rad Laboratories, Inc. Company Details
    Table 84. Bio-Rad Laboratories, Inc. Business Overview
    Table 85. Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Product
    Table 86. Bio-Rad Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 87. Bio-Rad Laboratories, Inc. Recent Development
    Table 88. Bio-Techne Corporation Cytek Biosciences Company Details
    Table 89. Bio-Techne Corporation Cytek Biosciences Business Overview
    Table 90. Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Product
    Table 91. Bio-Techne Corporation Cytek Biosciences Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 92. Bio-Techne Corporation Cytek Biosciences Recent Development
    Table 93. Cytognos, S.L. Company Details
    Table 94. Cytognos, S.L. Business Overview
    Table 95. Cytognos, S.L. Flow Cytometry in Oncology Product
    Table 96. Cytognos, S.L. Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 97. Cytognos, S.L. Recent Development
    Table 98. Danaher Corporation Company Details
    Table 99. Danaher Corporation Business Overview
    Table 100. Danaher Corporation Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 101. Danaher Corporation Recent Development
    Table 102. Miltenyi Biotec B.V. and Co. KG Company Details
    Table 103. Miltenyi Biotec B.V. and Co. KG Business Overview
    Table 104. Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Product
    Table 105. Miltenyi Biotec B.V. and Co. KG Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 106. Miltenyi Biotec B.V. and Co. KG Recent Development
    Table 107. Laboratory Corporation of America Holdings Company Details
    Table 108. Laboratory Corporation of America Holdings Business Overview
    Table 109. Laboratory Corporation of America Holdings Flow Cytometry in Oncology Product
    Table 110. Laboratory Corporation of America Holdings Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 111. Laboratory Corporation of America Holdings Recent Development
    Table 112. Luminex Corporation Company Details
    Table 113. Luminex Corporation Business Overview
    Table 114. Luminex Corporation Flow Cytometry in Oncology Product
    Table 115. Luminex Corporation Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 116. Luminex Corporation Recent Development
    Table 117. NeoGenomics Laboratories, Inc. Company Details
    Table 118. NeoGenomics Laboratories, Inc. Business Overview
    Table 119. NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Product
    Table 120. NeoGenomics Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 121. NeoGenomics Laboratories, Inc. Recent Development
    Table 122. Sony Corporation Company Details
    Table 123. Sony Corporation Business Overview
    Table 124. Sony Corporation Flow Cytometry in Oncology Product
    Table 125. Sony Corporation Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 126. Sony Corporation Recent Development
    Table 127. Thermo Fisher Scientific Inc Company Details
    Table 128. Thermo Fisher Scientific Inc Business Overview
    Table 129. Thermo Fisher Scientific Inc Flow Cytometry in Oncology Product
    Table 130. Thermo Fisher Scientific Inc Revenue in Flow Cytometry in Oncology Business (2016-2021) & (US$ Million)
    Table 131. Thermo Fisher Scientific Inc Recent Development
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Flow Cytometry in Oncology Market Share by Type: 2020 VS 2027
    Figure 2. Assays and Kits Features
    Figure 3. Instruments Features
    Figure 4. Reagents and Consumables Features
    Figure 5. Software Features
    Figure 6. Global Flow Cytometry in Oncology Market Share by Application: 2020 VS 2027
    Figure 7. Diagnostic Laboratories Case Studies
    Figure 8. Hospitals and Healthcare Centers Case Studies
    Figure 9. Academic and Research Institutions Case Studies
    Figure 10. Others Case Studies
    Figure 11. Flow Cytometry in Oncology Report Years Considered
    Figure 12. Global Flow Cytometry in Oncology Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Flow Cytometry in Oncology Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Flow Cytometry in Oncology Market Share by Regions: 2020 VS 2027
    Figure 15. Global Flow Cytometry in Oncology Market Share by Regions (2022-2027)
    Figure 16. Global Flow Cytometry in Oncology Market Share by Players in 2020
    Figure 17. Global Top Flow Cytometry in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flow Cytometry in Oncology as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Flow Cytometry in Oncology Revenue in 2020
    Figure 19. Global Flow Cytometry in Oncology Revenue Market Share by Type (2016-2021)
    Figure 20. Global Flow Cytometry in Oncology Revenue Market Share by Type (2022-2027)
    Figure 21. North America Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Flow Cytometry in Oncology Market Share by Type (2016-2027)
    Figure 23. North America Flow Cytometry in Oncology Market Share by Application (2016-2027)
    Figure 24. North America Flow Cytometry in Oncology Market Share by Country (2016-2027)
    Figure 25. United States Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Flow Cytometry in Oncology Market Share by Type (2016-2027)
    Figure 29. Europe Flow Cytometry in Oncology Market Share by Application (2016-2027)
    Figure 30. Europe Flow Cytometry in Oncology Market Share by Country (2016-2027)
    Figure 31. Germany Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Flow Cytometry in Oncology Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Flow Cytometry in Oncology Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Flow Cytometry in Oncology Market Share by Region (2016-2027)
    Figure 41. China Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Flow Cytometry in Oncology Market Share by Type (2016-2027)
    Figure 49. Latin America Flow Cytometry in Oncology Market Share by Application (2016-2027)
    Figure 50. Latin America Flow Cytometry in Oncology Market Share by Country (2016-2027)
    Figure 51. Mexico Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Flow Cytometry in Oncology Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Flow Cytometry in Oncology Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Flow Cytometry in Oncology Market Share by Country (2016-2027)
    Figure 57. Turkey Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Flow Cytometry in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Agilent Technologies, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 61. Apogee Flow Systems Ltd. Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 62. Becton, Dickinson and Company Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 63. bioAffinity Technologies, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 64. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 65. Bio-Techne Corporation Cytek Biosciences Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 66. Cytognos, S.L. Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 67. Danaher Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 68. Miltenyi Biotec B.V. and Co. KG Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 69. Laboratory Corporation of America Holdings Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 70. Luminex Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 71. NeoGenomics Laboratories, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 72. Sony Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 73. Thermo Fisher Scientific Inc Revenue Growth Rate in Flow Cytometry in Oncology Business (2016-2021)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Agilent Technologies, Inc.
Apogee Flow Systems Ltd.
Becton, Dickinson and Company
bioAffinity Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation Cytek Biosciences
Cytognos, S.L.
Danaher Corporation
Miltenyi Biotec B.V. and Co. KG
Laboratory Corporation of America Holdings
Luminex Corporation
NeoGenomics Laboratories, Inc.
Sony Corporation
Thermo Fisher Scientific Inc
Frequently Asked Questions
Flow Cytometry in Oncology report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Flow Cytometry in Oncology report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Flow Cytometry in Oncology report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports